Department of Medical Engineering, University of South Florida, Tampa, FL, USA.
RNA Biol. 2022 Jan;19(1):841-851. doi: 10.1080/15476286.2022.2084861.
Germline-encoded pattern recognition receptors [PRRs] in mammalian cells function in the detection of molecular patterns associated with pathogen invasion or cellular damage. A PRR subset is activated by the atypical presence and location of double-stranded RNA [dsRNA] or its synthetic analogue polyinosinic-polycytidylic acid [poly(I:C)], triggering pro-inflammatory signalling and death in many cell types. Poly(I:C) has been tested as a sole or combination cancer therapy in preclinical studies and clinical trials. The purpose of this study was to evaluate the effects of poly(I:C) transfection via electroporation on cell lines from a cancer of epithelial origin, 4T1 mammary carcinoma, and a cancer of mesenchymal origin, WEHI 164 fibrosarcoma. The effects of the poly(I:C) delivery on cell metabolism implicate the induction of cell death. A pro-inflammatory response was demonstrated by mRNA upregulation and the secretion of Type I interferon and several cytokines and chemokines. The mRNAs of dsRNA sensor DExD/H-box helicase 58/retinoic acid-inducible gene I protein [Ddx58/RIG-I] and sensor/co-sensor DEAH-box helicase 9 [Dhx9] were not regulated, but the mRNAs of RNA sensors toll-like receptor 3 [TLR3], interferon-induced with helicase C domain 1/melanoma differentiation-associated protein 5 [Ifih1/MDA5] and Z-DNA binding protein 1 [Zbp1] and co-sensors DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 [Ddx60] and interferon-inducible protein 204 [Ifi204] were upregulated in both cell lines. The mRNAs encoding signalling pathways components were present or upregulated in both cell types. These data demonstrate that RNA sensing effects can be amplified by electroporation delivery, potentially expanding the practicality of this immunotherapeutic approach.
哺乳动物细胞中的胚系编码模式识别受体 (PRR) 可在检测与病原体入侵或细胞损伤相关的分子模式中发挥作用。PRR 的一个亚类可被非典型双链 RNA (dsRNA) 或其合成类似物聚肌苷酸-聚胞苷酸 [poly(I:C)] 的存在和位置激活,在许多细胞类型中引发促炎信号和死亡。聚肌苷酸-聚胞苷酸已在临床前研究和临床试验中作为单一或联合癌症疗法进行了测试。本研究旨在评估通过电穿孔转染聚肌苷酸-聚胞苷酸对源自上皮来源的癌症 4T1 乳腺癌和源自间充质来源的癌症 WEHI 164 纤维肉瘤的细胞系的影响。聚肌苷酸-聚胞苷酸递送对细胞代谢的影响暗示诱导细胞死亡。通过上调 mRNA 和分泌 I 型干扰素以及几种细胞因子和趋化因子来证明促炎反应。dsRNA 传感器 DExD/H-框解旋酶 58/维甲酸诱导基因 I 蛋白 [Ddx58/RIG-I] 和传感器/共传感器 DEAH-框解旋酶 9 [Dhx9] 的 mRNA 未受调节,但 RNA 传感器 Toll 样受体 3 [TLR3]、干扰素诱导的具有螺旋酶 C 结构域 1/黑色素瘤分化相关蛋白 5 [Ifih1/MDA5] 和 Z-DNA 结合蛋白 1 [Zbp1] 和共传感器 DEAD (Asp-Glu-Ala-Asp) 框多肽 60 [Ddx60] 和干扰素诱导蛋白 204 [Ifi204] 的 mRNA 在两种细胞系中均上调。两种细胞类型均存在或上调了信号通路成分的 mRNA。这些数据表明,通过电穿孔递送可以放大 RNA 传感效应,从而可能扩大这种免疫治疗方法的实用性。